Antiretroviral therapy coverage in Algeria
Algeria: Antiretroviral therapy coverage was 68.0% in 2024. ◆ Volatile
Antiretroviral therapy coverage in Algeria, 2000–2024
Source: UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS). Measured in % of people living with HIV.
Analysis
The most recent figure for antiretroviral therapy coverage in Algeria is 68.0%, measured in 2024.
The figure is down 4.2% on the previous year and up 58.1% over ten years.
Over the whole period, antiretroviral therapy coverage in Algeria peaked at 74.0% in 2021 and was at its lowest, 6.0%, in 2000.
Algeria ranks 82nd of 143 countries on this measure, in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Antiretroviral therapy coverage in Algeria, year by year
| Year | % of people living with HIV | Change |
|---|---|---|
| 2000 | 6.0% | — |
| 2001 | 7.0% | +16.7% |
| 2002 | 8.0% | +14.3% |
| 2003 | 8.0% | +0.0% |
| 2004 | 9.0% | +12.5% |
| 2005 | 10.0% | +11.1% |
| 2006 | 13.0% | +30.0% |
| 2007 | 13.0% | +0.0% |
| 2008 | 13.0% | +0.0% |
| 2009 | 16.0% | +23.1% |
| 2010 | 21.0% | +31.2% |
| 2011 | 23.0% | +9.5% |
| 2012 | 28.0% | +21.7% |
| 2013 | 35.0% | +25.0% |
| 2014 | 43.0% | +22.9% |
| 2015 | 51.0% | +18.6% |
| 2016 | 59.0% | +15.7% |
| 2017 | 64.0% | +8.5% |
| 2018 | 69.0% | +7.8% |
| 2019 | 72.0% | +4.3% |
| 2020 | 72.0% | +0.0% |
| 2021 | 74.0% | +2.8% |
| 2022 | 69.0% | -6.8% |
| 2023 | 71.0% | +2.9% |
| 2024 | 68.0% | -4.2% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 10.3% | 6.0% | 16.0% | 10 |
| 2010s | 46.5% | 21.0% | 72.0% | 10 |
| 2020s | 70.8% | 68.0% | 74.0% | 5 |
Countries ranked near Algeria
More health data for Algeria
- Un projection of annual infant deaths, annual growth rate -1.82 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.5437 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 943.1 deaths per 1,000 people (2090)
- Number of infants who die before age 1 1,455 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -2.77 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0465 units per person (2025)
- Population ages 00-04, male, annual growth rate -2.77 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is antiretroviral therapy coverage in Algeria?
- Antiretroviral therapy coverage in Algeria was 68.0% in 2024, according to UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS).
- What is the highest antiretroviral therapy coverage recorded in Algeria?
- The highest recorded value was 74.0% in 2021.
- What is the lowest antiretroviral therapy coverage recorded in Algeria?
- The lowest recorded value was 6.0% in 2000.
- How does Algeria rank for antiretroviral therapy coverage?
- Algeria ranks 82nd out of 143 countries with data for 2024.
- Is antiretroviral therapy coverage rising or falling in Algeria?
- Over the last ten years it is up 58.1%. The long-run trend across the full record is volatile.
- Where does this Algeria data come from?
- The figures come from UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as part of Antiretroviral therapy coverage (% of people living with HIV). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Antiretroviral therapy coverage indicates the percentage of all people living with HIV who are receiving antiretroviral therapy.